Does AMIVANTAMAB-VMJW Cause Decreased appetite? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Decreased appetite have been filed in association with AMIVANTAMAB-VMJW. This represents 1.6% of all adverse event reports for AMIVANTAMAB-VMJW.
31
Reports of Decreased appetite with AMIVANTAMAB-VMJW
1.6%
of all AMIVANTAMAB-VMJW reports
7
Deaths
5
Hospitalizations
How Dangerous Is Decreased appetite From AMIVANTAMAB-VMJW?
Of the 31 reports, 7 (22.6%) resulted in death, 5 (16.1%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIVANTAMAB-VMJW. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does AMIVANTAMAB-VMJW Cause?
Infusion related reaction (509)
Rash (315)
Off label use (130)
Dyspnoea (81)
Paronychia (78)
Nausea (65)
Oxygen saturation decreased (55)
Flushing (54)
Death (53)
Non-small cell lung cancer (51)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which AMIVANTAMAB-VMJW Alternatives Have Lower Decreased appetite Risk?
AMIVANTAMAB-VMJW vs AMLODIPINE
AMIVANTAMAB-VMJW vs AMLODIPINE BESILATE
AMIVANTAMAB-VMJW vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB-VMJW vs AMLODIPINE\BENAZEPRIL
AMIVANTAMAB-VMJW vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN